Correlation Between Elevation Oncology and Clearside Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Clearside Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Clearside Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and Clearside Biomedical, you can compare the effects of market volatilities on Elevation Oncology and Clearside Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Clearside Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Clearside Biomedical.

Diversification Opportunities for Elevation Oncology and Clearside Biomedical

-0.42
  Correlation Coefficient

Very good diversification

The 3 months correlation between Elevation and Clearside is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Clearside Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clearside Biomedical and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Clearside Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clearside Biomedical has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Clearside Biomedical go up and down completely randomly.

Pair Corralation between Elevation Oncology and Clearside Biomedical

Given the investment horizon of 90 days Elevation Oncology is expected to under-perform the Clearside Biomedical. In addition to that, Elevation Oncology is 1.63 times more volatile than Clearside Biomedical. It trades about -0.14 of its total potential returns per unit of risk. Clearside Biomedical is currently generating about -0.01 per unit of volatility. If you would invest  125.00  in Clearside Biomedical on September 3, 2024 and sell it today you would lose (20.00) from holding Clearside Biomedical or give up 16.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Elevation Oncology  vs.  Clearside Biomedical

 Performance 
       Timeline  
Elevation Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Elevation Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Clearside Biomedical 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Clearside Biomedical are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Clearside Biomedical exhibited solid returns over the last few months and may actually be approaching a breakup point.

Elevation Oncology and Clearside Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elevation Oncology and Clearside Biomedical

The main advantage of trading using opposite Elevation Oncology and Clearside Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Clearside Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearside Biomedical will offset losses from the drop in Clearside Biomedical's long position.
The idea behind Elevation Oncology and Clearside Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Stocks Directory
Find actively traded stocks across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk